These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors. Ren S; Hesk D; McNamara P; Koharski D; Hendershot S J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525 [TBL] [Abstract][Full Text] [Related]
5. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite. Hickey MJ; Allen PH; Caffrey M; Hansen P; Kingston LP; Wilkinson DJ J Labelled Comp Radiopharm; 2016 Sep; 59(11):432-8. PubMed ID: 27461061 [TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Strizki JM; Tremblay C; Xu S; Wojcik L; Wagner N; Gonsiorek W; Hipkin RW; Chou CC; Pugliese-Sivo C; Xiao Y; Tagat JR; Cox K; Priestley T; Sorota S; Huang W; Hirsch M; Reyes GR; Baroudy BM Antimicrob Agents Chemother; 2005 Dec; 49(12):4911-9. PubMed ID: 16304152 [TBL] [Abstract][Full Text] [Related]
16. The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity. Tran SB; Maxwell BD; Burrell R; Bonacorsi SJ J Labelled Comp Radiopharm; 2016 Dec; 59(14):665-672. PubMed ID: 27624665 [TBL] [Abstract][Full Text] [Related]
17. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors. Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229 [TBL] [Abstract][Full Text] [Related]
18. Forward- and reverse-synthesis of piperazinopiperidine amide analogs: a general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists. Feng DZ; Song YL; Jiang XH; Chen L; Long YQ Org Biomol Chem; 2007 Aug; 5(16):2690-7. PubMed ID: 18019544 [TBL] [Abstract][Full Text] [Related]
19. Preparation of tritium-labeled PF-622, a novel fatty acid amide hydrolase inhibitor. Zhang Y J Labelled Comp Radiopharm; 2017 Nov; 60(13):608-615. PubMed ID: 28869999 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficiency of Pd/H2 -catalyzed benzylic H/D exchange of dehydroabietinal with D(2) O and synthesis of a tritium-labeled analogue. Petros RA; Shah J J Labelled Comp Radiopharm; 2014 Jan; 57(1):53-6. PubMed ID: 24448746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]